白内障手术后预防黄斑水肿的围手术期局部非甾体抗炎药应用
该回顾性匹配队列研究纳入108093例接受白内障手术的患者,其中89731例符合纳入标准,比较围手术期局部非甾体抗炎药(NSAID)联合局部激素与单用局部激素对术后90天内黄斑水肿(PME)诊断的影响。结果显示,NSAID使用与无糖尿病患者(RR 0.68,95%CI 0.58-0.72)及无视网膜病变的糖尿病患者(RR 0.51,95%CI 0.32-0.82)PME发生率降低相关,但在糖尿病视网膜病变患者中未见此关联(RR 1.06,95%CI 0.81-1.38)。
要点
- 56.4%的患者填写了NSAID处方,PME患病率在处方组为1.3%,未处方组为1.7%。
- 预防1例PME需治疗320例患者。
- 无糖尿病患者使用NSAID与PME发生率降低相关(RR 0.68,95%CI 0.58-0.72)。
核心结论
- 局部NSAID与白内障手术患者PME发生率轻度降低相关,但在糖尿病视网膜病变患者中未见此关系。
- PME风险较低,从治疗中获益的患者数量较少。
研究设计与样本
- 回顾性匹配队列研究,纳入2007年1月至2014年6月期间接受白内障手术的患者。
- 108093例Kaiser Permanente Southern California患者接受白内障手术,其中89731例符合纳入标准。
- 比较围手术期填写局部NSAID处方联合局部激素的患者与仅使用局部激素的患者。
- 主要结局指标为白内障手术后90天内黄斑水肿的诊断。
主要发现
- 56.4%的患者填写了NSAID处方。
- PME患病率在处方NSAID的患者中为1.3%,在未处方NSAID的患者中为1.7%。
- 预防1例PME需治疗320例患者。
- 在无糖尿病患者中,NSAID使用与PME发生率降低相关(RR 0.68,95%CI 0.58-0.72)。
- 在无视网膜病变的糖尿病患者中,NSAID使用与PME发生率降低相关(RR 0.51,95%CI 0.32-0.82);在糖尿病视网膜病变患者中,NSAID使用与PME发生率变化无关(RR 1.06,95%CI 0.81-1.38)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the effect of routine use of topical nonsteroidal anti-inflammatory drugs (NSAIDs) on the incidence of postoperative macular edema (PME) after cataract surgery. The role of diabetic retinopathy on the relationship between NSAID use and PME was further analyzed. DESIGN: Retrospective matched cohort study. METHODS: Patients undergoing cataract surgery between January 2007 and June 2014 were included in this study. A total of 108 093 Kaiser Permanente Southern California patients underwent cataract surgery and 89 731 met inclusion criteria. Cataract surgery patients who had a perioperative prescription of topical NSAIDs filled in addition to topical steroids were compared to those taking topical steroids only. The main outcome measure was the diagnosis of macular edema within 90 days of cataract surgery. RESULTS: A prescription for an NSAID was filled by 56.4% of patients. The prevalence of PME was 1.3% among those prescribed and 1.7% among those not prescribed NSAIDs. The number needed to treat was 320 patients to prevent 1 case of PME. A matched cohort analysis was performed to account for confounders. NSAID use was associated with a lower incidence of PME in patients without diabetes [relative risk (RR) 0.68, 95% confidence interval (CI) 0.58-0.72] and diabetics without retinopathy (RR 0.51, 95% CI 0.32-0.82). NSAID use was not associated with a change in the incidence of PME among patients with diabetic retinopathy (RR 1.06, 95% 0.81-1.38). CONCLUSION: Topical NSAIDs were associated with a modest reduction of PME incidence in patients undergoing cataract surgery; however, this relationship was not seen among those with diabetic retinopathy. The risk for PME is low and the number of patients benefiting from treatment is small.
引用
- Modjtahedi BS, Paschal JF, Batech M, et al. Perioperative Topical Nonsteroidal Anti-inflammatory Drugs for Macular Edema Prophylaxis Following Cataract Surgery. Am J Ophthalmol. 2017. PMID: 28104415. doi:10.1016/j.ajo.2017.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。